Nothing not to like here. A good update. Costs in check and...

Nothing not to like here. A good update. Costs in check and plenty of cash in the bank. Development milestones hit on time and on budget. They did mention in a previous update about recruiting patients for trial 7 in Q1 ‘19. It seems they need to upscale and finalise kit development and commence trial 6 (concurrently?) before that will happen so it’s likely a ways down the track. Rhy is the long game and I’m sure there’s a lot going on behind the scenes and Rhythm are building relationships with partners, government and the healthcare community to make Colostat a reality. Hopefully regular updates to follow...